Arcutis Biotherapeutics Inc. (ARQT) PT Lowered to $50 at Morgan Stanley

July 16, 2021 4:06 AM EDT Send to a Friend

Morgan Stanley analyst David Lebowitz ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Arcutis Biotherapeutics Inc. (ARQT) PT Lowered to $50 at Morgan Stanley

Member Login

Free News Feed